Whilst this decrease of IgG fucosylation did not reach statistical significance in patients with axSpA, this trend is consistent with previous studies on related autoimmune diseases, such as SLE and ulcerative colitis [ 19 – 21 ].
← all excerpts
Profiling of IgG N-glycosylation for axial spondyloarthritis and other rheumatic diseases.
1
—
—